graph digitizer software version 2.20 (GetData Pty Ltd)
90
Structured Review
GetData Pty Ltd
graph digitizer software version 2.20
Graph Digitizer Software Version 2.20, supplied by GetData Pty Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graph+digitizer+software+version+2%2E20/graph+digitizer/10__1097_slash_js9__0000000000002344-85-20-20
Average 90 stars, based on 1 article reviews
Graph Digitizer Software Version 2.20, supplied by GetData Pty Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graph+digitizer+software+version+2%2E20/graph+digitizer/10__1097_slash_js9__0000000000002344-85-20-20
Average 90 stars, based on 1 article reviews
graph digitizer software version 2.20 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: Economic Evaluation of Adding Daratumumab to Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma Article Snippet: Initially, data points from the survive curves (including PFS and OS of the two arms) were extracted using Article Title: CDK4/6 Inhibitors in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: An Updated Network Meta-Analysis and Cost-Effectiveness Analysis. Article Snippet: Article Title: Efficacy of Resveratrol in Experimental Subarachnoid Hemorrhage Animal Models: A Stratified Meta-Analysis Article Snippet: For graphical data, Article Title: Cerebrospinal fluid biomarkers of neuroinflammation and postoperative neurocognitive disorders in patients undergoing orthopedic surgery Article Snippet: Two researchers (HF, YL) manually extracted all the data using a pre-designed form, and graphical data were extracted using the Article Title: CDK4/6 Inhibitors in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: An Updated Network Meta-Analysis and Cost-Effectiveness Analysis. Article Snippet: Article Title: CDK4/6 Inhibitors in the First-Line Treatment of Postmenopausal Women with HR+/HER2− Advanced or Metastatic Breast Cancer: An Updated Network Meta-Analysis and Cost-Effectiveness Analysis Article Snippet: Standard Deviation:Article Title: Economic Evaluation of Adding Daratumumab to Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma Article Snippet: Initially, data points from the survive curves (including PFS and OS of the two arms) were extracted using Article Title: CDK4/6 Inhibitors in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: An Updated Network Meta-Analysis and Cost-Effectiveness Analysis. Article Snippet: Article Title: Efficacy of Resveratrol in Experimental Subarachnoid Hemorrhage Animal Models: A Stratified Meta-Analysis Article Snippet: For graphical data, Article Title: Cerebrospinal fluid biomarkers of neuroinflammation and postoperative neurocognitive disorders in patients undergoing orthopedic surgery Article Snippet: Two researchers (HF, YL) manually extracted all the data using a pre-designed form, and graphical data were extracted using the Article Title: CDK4/6 Inhibitors in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: An Updated Network Meta-Analysis and Cost-Effectiveness Analysis. Article Snippet: Article Title: CDK4/6 Inhibitors in the First-Line Treatment of Postmenopausal Women with HR+/HER2− Advanced or Metastatic Breast Cancer: An Updated Network Meta-Analysis and Cost-Effectiveness Analysis Article Snippet: |